Leonardo Roever: The Role of Non-Pharmacological Interventions in Post-Stroke Quality of Life
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Ha-Young Park and Insun Yeom, published in Quality of Life Research:
”Effects of Non-Pharmacological Interventions on Post-Stroke Quality of Life: A Meta-Regression
Stroke remains a leading cause of long-term disability, with survivors experiencing a substantial decline in health-related quality of life (HRQoL).
While non-pharmacological interventions (NPIs) are known to improve HRQoL, it remains unclear which modalities are most effective and which planning features maximize HRQoL outcomes.
In addition to confirming the overall benefits of NPIs, this study demonstrates that both the modality and duration of the intervention are key determinants of HRQoL improvement after a stroke.
These findings provide evidence-based guidance on how non-pharmacological rehabilitation programs should be structured, highlighting the importance of psychosocial components and sustained intervention duration to maximize quality of life outcomes in stroke survivors.”
Title: Effects of nonpharmacological interventions on post-stroke quality of life: a systematic review, meta-analysis, and meta-regression
Authors: Ha-Young Park, Insun Yeom
Read the Full Article on Quality of Life Research
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 1, 2026, 16:41Axel Diederichsen: Can Vitamin K2 and Vitamin D3 Slow the Progression of Severe Coronary Artery Calcification?
-
Sep 1, 2026, 16:15Sangeeta Pathak: The Bombay Blood Group as a Very Rare Phenotype
-
Sep 1, 2026, 16:14The Ecuador 2026 National Conference on Coagulation Disorders – WFH
-
Sep 1, 2026, 15:54Alejandro González Veliz: Can Treating Tricuspid Regurgitation Change Outcomes?
-
Sep 1, 2026, 15:51Ingo Ahrens: Another Step Forward in Catheter-Directed Thrombolysis for Acute PE
-
Sep 1, 2026, 15:20Sohail Khan: What Comes After IV Thrombolysis
-
Sep 1, 2026, 15:09Harish Chowdary Gorrepati: The HALT Paradox After TAV
-
Sep 1, 2026, 14:53Josef Kroupa: Landmark PRAGUE-26 Trial Advances Interventional PE Treatment
-
Sep 1, 2026, 14:34Marcin Kurzyna: New NEJM Trial Evaluates Catheter-Directed Thrombolysis in PE